Abraxane® (paclitaxel, protein-bound) – First-time authorized brand alternative

Dynamic Alerts

Review Optum Rx Formulary changes effective 1/1/25 :

New: Biosimilars strategies introduced.

View Updates

Site Logo

Health care professionals website

DPL Global Search

DPL Main Nav

DPL Global Search

Breadcrumbs

Text

Abraxane^®(paclitaxel, protein-bound) – First-time authorized brand alternative

April 12, 2022 - Apotex and TWi Pharmaceuticals launched authorized brand alternatives of Abraxis BioScience’s Abraxane (paclitaxel, protein-bound) injection.

Download PDF

Text

Return to publications

Top

RxNews®

Abraxane®(paclitaxel, protein-bound) – First-time authorized brand alternative

Abraxane^®(paclitaxel, protein-bound) – First-time authorized brand alternative